Dee Lin

471 total citations
45 papers, 284 citations indexed

About

Dee Lin is a scholar working on Psychiatry and Mental health, Hematology and Oncology. According to data from OpenAlex, Dee Lin has authored 45 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 18 papers in Hematology and 10 papers in Oncology. Recurrent topics in Dee Lin's work include Schizophrenia research and treatment (19 papers), Multiple Myeloma Research and Treatments (18 papers) and Mental Health Treatment and Access (9 papers). Dee Lin is often cited by papers focused on Schizophrenia research and treatment (19 papers), Multiple Myeloma Research and Treatments (18 papers) and Mental Health Treatment and Access (9 papers). Dee Lin collaborates with scholars based in United States, United Kingdom and Canada. Dee Lin's co-authors include Carmela Benson, Patrick Lefèbvre, Marie‐Hélène Lafeuille, Isabelle Ghelerter, Panagiotis Mavros, Ha Nam Nguyen, Philippe Thompson‐Leduc, Kruti Joshi, Charmi Patel and Laura Morrison and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Dee Lin

40 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dee Lin United States	10	184	62	53	44	35	45	284
Michael Durkin United States	10	197 1.1×	28 0.5×	28 0.5×	68 1.5×	94 2.7×	25	327
Mark Ratcliffe United Kingdom	7	162 0.9×	60 1.0×	24 0.5×	48 1.1×	108 3.1×	9	324
Ricarda Windisch Switzerland	4	138 0.8×	21 0.3×	44 0.8×	53 1.2×	36 1.0×	6	303
Tomasz Gondek Poland	7	68 0.4×	11 0.2×	45 0.8×	59 1.3×	8 0.2×	38	234
E. B. Renvoize United Kingdom	12	68 0.4×	20 0.3×	14 0.3×	81 1.8×	9 0.3×	30	361
Elizabeth Khaykin United States	6	105 0.6×	9 0.1×	34 0.6×	43 1.0×	22 0.6×	6	235
Mete Şaylan Türkiye	9	123 0.7×	10 0.2×	13 0.2×	82 1.9×	19 0.5×	30	254
Yiqi Pan Germany	12	88 0.5×	13 0.2×	22 0.4×	86 2.0×	10 0.3×	15	367
David Firth United Kingdom	7	69 0.4×	32 0.5×	10 0.2×	40 0.9×	8 0.2×	12	348
Saifuddin Kharawala United States	8	77 0.4×	21 0.3×	8 0.2×	27 0.6×	12 0.3×	13	225

Countries citing papers authored by Dee Lin

Since Specialization

Citations

This map shows the geographic impact of Dee Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dee Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dee Lin more than expected).

Fields of papers citing papers by Dee Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dee Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dee Lin. The network helps show where Dee Lin may publish in the future.

Co-authorship network of co-authors of Dee Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Dee Lin. A scholar is included among the top collaborators of Dee Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dee Lin. Dee Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dhakal, Binod, Nina Kim, William S. John, et al.. (2024). Real-World Patient Characteristics and Outcomes in Patients with Relapsed or Refractory Multiple Myeloma Receiving Teclistamab across Community Oncology Practices in the US. Blood. 144(Supplement 1). 7843–7843. 1 indexed citations

Beer, Tomasz M., et al.. (2024). Dosing Patterns and Early Safety and Effectiveness Outcomes in Patients with Multiple Myeloma Treated with Teclistamab in the Community Setting. Blood. 144(Supplement 1). 2398–2398. 1 indexed citations

Huntington, Scott F., Dee Lin, Marie‐Hélène Lafeuille, et al.. (2024). Identification of cytokine release syndrome and indicators of severity in retrospective databases among patients receiving immunotherapy. Pharmacology Research & Perspectives. 12(6). e70024–e70024.

Neparidze, Natalia, et al.. (2024). Patient Perspectives on Social and Identity Factors Affecting Multiple Myeloma Care: Barriers and Opportunities. Healthcare. 12(16). 1587–1587. 1 indexed citations

Neparidze, Natalia, et al.. (2024). Impact of Social Needs and Identity Experiences on the Burden of Illness in Patients with Multiple Myeloma: A Mixed-Methods Study. Healthcare. 12(16). 1660–1660. 1 indexed citations

Neparidze, Natalia, et al.. (2024). Impact of Social Needs and Identity Experiences on the Burden of Illness for Patients with Multiple Myeloma: A Mixed-Methods Study. Clinical Lymphoma Myeloma & Leukemia. 24. S238–S238. 1 indexed citations

Levy, Yair, Nina Kim, Bingcao Wu, et al.. (2024). Real-World Characteristics, Step-up Dosing Patterns, and Outcomes in Patients with Multiple Myeloma Receiving Teclistamab at Texas Oncology Community-Based Treatment Centers. Blood. 144(Supplement 1). 7851–7851.

Afrough, Aimaz, Nina Kim, Jinghua He, et al.. (2024). Real-World Characteristics and Outcomes in Patients with Multiple Myeloma Receiving Teclistamab Step-up Doses in Academic Vs. Community Settings. Blood. 144(Supplement 1). 933–933.

Lin, Dee, Bingcao Wu, Nina Kim, et al.. (2024). Patient perspectives on BCMA-targeted therapies for multiple myeloma: a survey conducted in a patient advocacy group. SHILAP Revista de lepidopterología. 4. 1354760–1354760. 2 indexed citations

10.

Tan, Carlyn, Andriy Derkach, Kylee Maclachlan, et al.. (2024). Real-world schedule de-escalation of teclistamab in patients with relapsed/refractory multiple myeloma.. Journal of Clinical Oncology. 42(16_suppl). 7536–7536. 8 indexed citations

11.

Neparidze, Natalia, et al.. (2023). A Mixed Methods Study to Describe the Relationship between Burden of Illness, Social Needs, and Identity Experiences Among Patients with Multiple Myeloma. Blood. 142(Supplement 1). 7353–7353. 1 indexed citations

12.

Correll, Christoph U., Carmela Benson, Bruno Émond, et al.. (2023). Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategies. Schizophrenia. 9(1). 9–9. 11 indexed citations

13.

Lin, Dee, et al.. (2023). Budget impact of introducing once-every-6-months paliperidone palmitate in US health care plans. Journal of Managed Care & Specialty Pharmacy. 29(3). 303–313. 2 indexed citations

14.

Keenan, Alexander, et al.. (2022). Patient-psychiatrist discordance and drivers of prescribing long-acting injectable antipsychotics for schizophrenia management in the real-world: a point-in-time survey. BMC Psychiatry. 22(1). 187–187. 8 indexed citations

15.

Lin, Dee, et al.. (2022). Unemployment, homelessness, and other societal outcomes in patients with schizophrenia: a real-world retrospective cohort study of the United States Veterans Health Administration database. BMC Psychiatry. 22(1). 458–458. 25 indexed citations

16.

Zhdanava, Maryia, Dee Lin, Marie‐Hélène Lafeuille, et al.. (2021). Antipsychotic Adherence, Resource Use, and Costs Before and After the Initiation of Once-monthly Paliperidone Palmitate Therapy Among Medicaid Beneficiaries With Prior Schizophrenia Relapse. Clinical Therapeutics. 43(3). 535–548. 10 indexed citations

17.

Lin, Dee, Philippe Thompson‐Leduc, Isabelle Ghelerter, et al.. (2021). Correction to: Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis. CNS Drugs. 35(8). 923–923. 2 indexed citations

18.

Lin, Dee, Kruti Joshi, Alexander Keenan, et al.. (2021). Associations Between Relapses and Psychosocial Outcomes in Patients With Schizophrenia in Real-World Settings in the United States. Frontiers in Psychiatry. 12. 695672–695672. 20 indexed citations

19.

Danne, Thomas, Vijay N. Joish, Phillip Banks, et al.. (2020). Improvement in Patient-Reported Outcomes in Adults with Type 1 Diabetes Treated with Sotagliflozin plus Insulin Versus Insulin Alone. Diabetes Technology & Therapeutics. 23(1). 70–77. 7 indexed citations

20.

Lin, Dee, Mary Barna Bridgeman, & Luigi Brunetti. (2019). Evaluation of alterations in serum immunoglobulin concentrations in components of metabolic syndrome, obesity, diabetes, and dyslipidemia. BMC Cardiovascular Disorders. 19(1). 319–319. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact